Skip to main content
Erschienen in: Intensive Care Medicine 4/2020

26.02.2020 | Letter

Prolonged elevation of plasma HMGB1 is associated with cognitive impairment in intensive care unit survivors

verfasst von: Emily Brück, Julie Lasselin, Ulf Andersson, Peter V. Sackey, Peder S. Olofsson, The HICUS study group

Erschienen in: Intensive Care Medicine | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Excerpt

Dear Editor, …
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Wolters AE, Slooter AJ, van der Kooi AW, van Dijk D (2013) Cognitive impairment after intensive care unit admission: a systematic review. Intensive Care Med 39(3):376–386CrossRef Wolters AE, Slooter AJ, van der Kooi AW, van Dijk D (2013) Cognitive impairment after intensive care unit admission: a systematic review. Intensive Care Med 39(3):376–386CrossRef
2.
Zurück zum Zitat Chavan SS, Huerta PT, Robbiati S, Valdes-Ferrer SI, Ochani M, Dancho M, et al (2012) HMGB1 mediates cognitive impairment in sepsis survivors. Mol Med 18:930–7 Chavan SS, Huerta PT, Robbiati S, Valdes-Ferrer SI, Ochani M, Dancho M, et al (2012) HMGB1 mediates cognitive impairment in sepsis survivors. Mol Med 18:930–7
3.
Zurück zum Zitat Okuma Y, Wake H, Teshigawara K, Takahashi Y, Hishikawa T, Yasuhara T et al (2019) Anti-high mobility group box 1 antibody therapy may prevent cognitive dysfunction after traumatic brain injury. World Neurosurg. 122:e864–e871CrossRef Okuma Y, Wake H, Teshigawara K, Takahashi Y, Hishikawa T, Yasuhara T et al (2019) Anti-high mobility group box 1 antibody therapy may prevent cognitive dysfunction after traumatic brain injury. World Neurosurg. 122:e864–e871CrossRef
4.
Zurück zum Zitat Zhang J, Takahashi HK, Liu K, Wake H, Liu R, Maruo T et al (2011) Anti-high mobility group box-1 monoclonal antibody protects the blood-brain barrier from ischemia-induced disruption in rats. Stroke 42(5):1420–1428CrossRef Zhang J, Takahashi HK, Liu K, Wake H, Liu R, Maruo T et al (2011) Anti-high mobility group box-1 monoclonal antibody protects the blood-brain barrier from ischemia-induced disruption in rats. Stroke 42(5):1420–1428CrossRef
5.
Zurück zum Zitat Andersson U, Yang H, Harris H (2018) Extracellular HMGB1 as a therapeutic target in inflammatory diseases. Expert Opin Ther Targets. 22(3):263–277CrossRef Andersson U, Yang H, Harris H (2018) Extracellular HMGB1 as a therapeutic target in inflammatory diseases. Expert Opin Ther Targets. 22(3):263–277CrossRef
Metadaten
Titel
Prolonged elevation of plasma HMGB1 is associated with cognitive impairment in intensive care unit survivors
verfasst von
Emily Brück
Julie Lasselin
Ulf Andersson
Peter V. Sackey
Peder S. Olofsson
The HICUS study group
Publikationsdatum
26.02.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
Intensive Care Medicine / Ausgabe 4/2020
Print ISSN: 0342-4642
Elektronische ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-020-05941-7

Weitere Artikel der Ausgabe 4/2020

Intensive Care Medicine 4/2020 Zur Ausgabe

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.